Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

ELOVL4 antibody

The Rabbit Polyclonal anti-ELOVL4 antibody has been validated for WB. It is suitable to detect ELOVL4 in samples from Human.
Catalog No. ABIN307133

Quick Overview for ELOVL4 antibody (ABIN307133)

Target

See all ELOVL4 Antibodies
ELOVL4 (ELOVL Fatty Acid Elongase 4 (ELOVL4))

Reactivity

  • 35
  • 15
  • 11
  • 5
  • 2
  • 2
Human

Host

  • 36
Rabbit

Clonality

  • 36
Polyclonal

Conjugate

  • 18
  • 5
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This ELOVL4 antibody is un-conjugated

Application

  • 26
  • 23
  • 7
  • 5
  • 4
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB)
  • Cross-Reactivity

    Human

    Characteristics

    Elongation of very long chain fatty acids protein 4, ELOV4,Mutations in elongation of very long-chain fatty acid-4 (ELOVL4) are associated with autosomal dominant Stargardt-like macular degeneration (STGD3), with a five base-pair (5 bp) deletion mutation resulting in the loss of 51 carboxy-terminal amino acids and truncation of the protein. Elovl4 is expressed in the retina and only a limited number of mammalian other tissues, including skin, with unknown function. In a mouse model with the 5-bp deletion in the Elovl4 gene, mice in the heterozygous state (Elovl4(+/del)) demonstrate progressive photoreceptor degeneration. Homozygous mice (Elovl4(del/del)) display scaly, wrinkled skin, have severely compromised epidermal permeability barrier function, and die within a few hours after birth. Lipid analyses of epidermis from Elovl4(del/del) mice show a decrease in very long-chain fatty acids (VLFAs) in both the ceramide/glucosylceramide and the free fatty-acid fractions. ELOVL4 is required for generating VLFA critical for epidermal barrier function.

    Purification

    Ammonium Sulfate Precipitation

    Immunogen

    Synthetic peptdide derived from the human ELOV4 protein

    Isotype

    IgG
  • Application Notes

    Antibody can be used for Western blotting (1-5 μg/mL starting dilution). Optimal concentration should be evaluated by serial dilutions.

    Restrictions

    For Research Use only
  • Buffer

    Provided as solution in phosphate buffered saline with 0.08 % sodium azide

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C

    Storage Comment

    Product should be stored at -20°C. Aliquot to avoid freeze/thaw cycles
  • Target

    ELOVL4 (ELOVL Fatty Acid Elongase 4 (ELOVL4))

    Alternative Name

    ELOVL4

    UniProt

    Q9GZR5
You are here:
Chat with us!